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Summary
Objective: To study the impact of improved treatment outcome of a cohort of patients treated under DOTS strategy
on the prevalence of pulmonary tuberculosis (TB) in the community.
Design: The data from TB register of one Tuberculosis Unit (TU) in Tiruvallur district of Tamilnadu, and two TB
disease surveys conducted in the same area during 1999-2003 were analysed. The successful treatment outcome was
compared to the prevalence of TB in the subsequent cohort.
Results: The proportion of patients who completed treatment successfully was 75.3% in the first cohort period.  This
higher proportion of treatment success among patients treated under DOTS in the first cohort period (1999-2001)
compared to the 51-55% reported during SCC, resulted in a lower prevalence of smear-positive cases, irrespective of
culture results observed in the survey conducted during 2001-2003 compared to that in the survey conducted during
1999-2001 (252 vs. 323 per 100,000; annual decline of 9%). Similarly, a decline in culture-positive cases, irrespective
of smear results, was also observed (443 vs. 605; annual decline 11%).
Conclusion: The higher proportion of successful completion of treatment after DOTS implementation was associated
with a substantial decline in the prevalence of TB. These findings showed that we are in the direction towards achieving
the Millennium Development Goals (MDGs).
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INTRODUCTION
Tuberculosis (TB) is highly prevalent in
India in terms of morbidity and mortality1. It is
estimated that India accounts for one-fifth of
world’s new TB cases. World Health Organization
(WHO) declared tuberculosis a global public health
emergency in 1993 because of the high mortality
rate among adults, its association with HIV
infection and emergence of Multi-Drug Resistance
(MDR) TB. After the failure of the National
Tuberculosis Programme (NTP) as reviewed in
1992, Government of India revised the
tuberculosis control and launched the Directly
Observed Treatment Short course (DOTS) under
the Revised National Tuberculosis Control
Programme (RNTCP) with the aim of achieving
85% cure among new patients diagnosed to have
pulmonary tuberculosis and detect at least 70%
of the cases in the community2.
The key components of DOTS strategy are
political commitment, sputum diagnosis by smear
microscopy, short course chemotherapy under
direct supervision, uninterrupted supply of drugs,
monitoring, recording and evaluation of the
programme. This is an effective and successive
programme for the control of the disease.
Tuberculosis Research Centre (TRC) in
collaboration with Government of Tamil Nadu
established a centre in one TU of Tiruvallur district,
Tamil Nadu for DOTS implementation, tuberculosis
control, training and research.
Government of Tamil Nadu implemented the
DOTS strategy in the year 1999 in Tiruvallur district.
There are 17 health facilities (HFs) in the study area.
Under the DOTS programme, patients are detected
by symptom screening at this HFs through the
examinations of three sputum smears for acid-fast
bacilli. All patients diagnosed based on three sputum
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examinations are put on anti-TB treatment.  In this
strategy, smear microscopy is the most efficient
means of case detection among those persisting with
symptoms suggestive of pulmonary tuberculosis
(cough of three weeks or more with or without other
clinical symptoms). All patients diagnosed with
tuberculosis are given directly observed treatment
in accordance with RNTCP policies2. All the smears
are stained and examined by Ziehl – Neelson
microscopy for detection of tuberculosis. If the
patient is positive on smear microscopy on at least
two specimens and not treated previously for TB
for more than one month, he is termed as new
sputum smear-positive case and put on Category I
regimen 2(HRZE)3 /4(HR)3 (H-isoniazid; R-
rifampicin; Z=pyrazinamide; E=ethambutol; S-
streptomycin). Numbers before the letters indicates
the duration in months and that in subscript indicates
the number of times the drug given in each week).
If the patient is sputum smear-positive and treated
for more than a month, he is treated under Category
II regimen 2(HRZES)3 /1(HRZE)3 / 5(HRE)3.  Such
patients will be either a relapse case after declaring
cure when treated first or failure case or default
case.  Other sputum smear-negative cases not
seriously ill, extra pulmonary cases are put on
Category III regimen 2(HRZ)3 /4(HRE)3. In case,
the smear is positive only on one specimen out of
three specimens examined, the patient is prescribed
for one week antibiotic treatment and reviewed after
a week with a chest X-ray.  If the symptom is still
persisting, the patient is put on Category III regimen.
Intensive phase treatment of patients in categories I
and II is extended for one month if the smear is
positive at the end of the intensive phase.  Every
dose of treatment is to be directly observed in the
initial intensive phase of treatment and at least the
first of the three doses is to be directly observed
during the continuation phase.
Before the implementation of DOTS, the
Government of India introduced Short
Chemotherapy (SCC) on a pilot basis in the District
Tuberculosis Programme in 18 districts spread over
India. A concurrent cohort analysis of the data
collected from these districts during 1985-1991
showed that the overall treatment completion for
SCC was 51-55% with a case finding of 41%3. Two
community surveys were conducted in Tiruvallur
district, Tamil Nadu during 1999-2001 and 2001-
2003 to estimate the prevalence of pulmonary TB.
Patients who were diagnosed based on smear and/
or culture were referred and treated under DOTS
as per RNTCP guidelines. From the first survey,
the prevalence of pulmonary TB was estimated to
be 323 per 100, 000 for smear-positive cases and
605 per 100, 000 for culture-positive cases4. These
estimates served as the baseline information at the
end of the SCC and start of the DOTS
implementation.
This paper describes the treatment outcome
of a cohort of patients registered under DOTS and
compares with the prevalence of TB as estimated
from the disease surveys conducted  after the
implementation of the DOTS strategy.
MATERIAL AND METHODS
The study area is a rural population of
Tiruvallur district in Tamilnadu where TRC
monitored the DOTS programme for a period of
about six years since its implementation in 1999.
Patients diagnosed at any one of the HFs were treated
for TB as per the RNTCP guidelines2. TRC has
undertaken a series of disease surveys at every two
and-a-half years to measure the epidemiological
impact of DOTS implemented from 1999 in
Tiruvallur district. These disease surveys were
undertaken in a random sample of 82,000 adults
aged 15 years or more. The sample size estimated
for community disease survey was  based on an
annual incidence of culture-positive TB of 260 per
100,000 population, a precision of 20% at 95%
confidence level, with the coverage of examined
population 9% and a design effect of two.  The
methodology of survey is explained elsewhere4. In
each survey, all persons in the selected villages/units
were registered by door-to-door census and all adults
aged >15 years were questioned about chest
symptoms and underwent chest radiograph (70 mm
photo-fluorogram posteroanterior view) at a nearby
centre. For those with an abnormal radiograph
suggestive of TB and/or chest symptoms, attempts
were made to collect two sputum specimens. Those
who were absent for examinations were revisited
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the same day or on subsequent days until at least
90% had the required investigations. The sputum
specimens were examined by fluorescence
microscopy and cultured on Lowenstein-Jensen
medium. Those yielding growth were subjected to
identification tests for Mycobacterium tuberculosis
and drug susceptibility tests. A case of tuberculosis
was defined as a person with a positive smear (>3
acid-fast bacilli) irrespective of culture results.
The details of all patients started on
treatment in a TU are entered in a register called
Tuberculosis Register (TB Register) and these
patients are monitored in accordance with the
RNTCP guidelines. This register is maintained by
the Senior Treatment Supervisor (STS).  The TB
Register is the backbone of the DOTS strategy.
Every patient put on treatment is registered under a
specific TB number. A TB patient is known by this
number and the year in which he/she was registered.
The particulars like name, age, sex, category, type,
smear result at admission, 2nd /3rd month, 4th /5th
month and at the end of treatment are the details
entered in the TB Register.  The treatment outcome
of the patient is an important parameter of the
programme available in the TB Register. The
international definitions were followed to classify
TB patients according to outcome as follows5:
1. Cured: Initially smear-positive patient who
has completed treatment and had negative
sputum smears, on at least two occasions,
one of which was at completion of
treatment.
2. Treatment Completed:  Sputum smear-
positive case who has completed treatment,
with negative smears at the end of the initial
phase but none at the end of treatment (or)
Sputum smear-negative TB patient who has
received a full course of treatment and has
not become smear-positive during or at the
end of treatment (or) extra-pulmonary TB
patient who has received a full course of
treatment and has not become smear-
positive during or at the end of treatment.
3. Default:  A patient who, at any time after
registration, has not taken anti-TB drugs for
2 months or more consecutively
4. Expired/Died:  Patient who died during
treatment, regardless of cause.
5. Failure:  Smear-positive case who is smear-
positive at five months or more after starting
treatment.  Also, a patient who was initially
smear-negative but who became smear-
positive during treatment.
6. Transferred out:  A patient who has been
transferred to another TU/District and his/
her treatment results are not known.
All new TB patients identified in the two
prevalence surveys and treated under DOTS along
with  other new smear-positive cases detected from
other areas not included in the sample and registered
in the TU from May 1999 to June 2001 formed the
study population.. The data collected from the study
was computerized, edited and corrected for any
discrepancies. The proportion of patients who
successfully completed the treatment was obtained.
The potential risk factors for a higher likelihood of
default from treatment were identified. The
prevalence of the smear-positive and culture-positive
cases was estimated from the second survey and
compared to that in the first survey. Chi-square test
of significance was used to test the difference in
proportions. A p value of < 0.05 was considered as
statistically significant.
RESULTS
A total of 805 new smear- positive TB
patients were registered during the above period;
successful treatment completion rate was 75.3%
and 15.9% had defaulted.  The prevalence of TB
(smear-positive cases irrespective of culture results
and culture-positive cases irrespective of smear
results) estimated from the first survey and second
survey is in Table 14. The prevalence of smear-
positive cases, irrespective of culture results, was
252 in the second survey as compared to 323 per
100,000 in the first survey. The corresponding
figures for culture-positive cases were 443 and 605
per 100,000 respectively. The annual decline in the
prevalence of smear-positive cases from the first
survey and second survey was estimated to be 9%.
The corresponding figure for culture- positive cases
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* Irrespective of culture     ** irrespect ive of smea r 
 
Survey (round) Population Smear 
posit ive* 
Culture 
positive** 
First  survey 
(1999-2001) 
83390 323 605 
 
Second survey 
(2001-2003) 
 
85472 
 
 
252 
 
443 
Annual dec line (%) - 9 11 
Table 2: Risk factors for default of patients registered during 1999-2001under a DOTS programme
in Tiruvallur district, Tamil Nadu
Annual decline (%) =
Table 1:  Prevalence of pulmonary tuberculosis (per 100000) in two disease surveys conducted
during 1999-2001 and   2001-2003 in a TU in Tiruvallur district, Tamil Nadu.
(P1 - P2) x 100
P1  x N
P1 and P2 are the prevalence at two time
points at an interval of ‘N’ years.
Factors Number*  Default (%) P value 
Age <45 
>45 
358 
376 
44   (12.3) 
84   (22.3) 
P<0.001 
Sex 
 
Male 
Female 
581 
153 
114 (19.6) 
14    (9.2) 
P<0.01 
 
Education 
 
Illiterate 
Literate 
316 
348 
56   (17.7) 
47   (13.5) 
P=0.1 
Occupation Un-employed 
Employed 
173 
493 
32   (18.5) 
72    (14.6) 
P=0.2 
Patient’s 
Delay 
< 4 weeks 
> 4 weeks 
508 
136 
78   (15.4) 
19   (14.0) 
P=0.7 
DOTS 
convenient 
No 
Yes 
97 
447 
19   (19.6) 
72   (16.1) 
P=0.4 
Smoking No 
Yes 
350 
314 
32    (9.1) 
71  (22.6) 
P<0.001 
Alcoholism No 
Yes 
438 
227 
40    (9.1) 
63  (27.8) 
P<0.001 
DOTS 
provider 
Private 
Government 
272 
394 
44  (16.2) 
57   (14.5) 
P=0.5 
DOTS centre  Private 
Government 
333 
333 
60   (18.0)  
41   (12.3) 
P<0.05 
Supervision- 
during IP 
No 
Yes 
203 
461 
27   (13.3) 
74   (16.0) 
P=0.4 
*Those successfully completed treatment including default 
Note: For variables except for sex and age, the number of patients  
is less than 734 due to non-availability of all patients at the time  
of interview. 
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was 11%. After the implementation of DOTS during
this cohort period, case detection was about 80%
with a cure rate of 75%. This has resulted in a lower
prevalence of smear-positive as well as culture-
positive cases in the subsequent survey (323 to 252
and 605 to 443 per 100,000 respectively).
Risk factors for default: The distribution
of patients according to those successfully
completed the treatment and defaulted is given in
the Table 2. A uni-variate analysis  showed that a
higher default was significantly associated with
patient’s sex (male), aged < 45 years,  smoking,
alcoholism and the DOTS centre (private) where
patients took treatment. A multivariate analysis
showed that age and alcoholism were the
independent risk factors associated with a higher
likelihood of default.
DISCUSSION
The Tiruvallur area provides a unique
opportunity to evaluate the TB situation before
and after implementation of DOTS. The
epidemiological data generated during the 15 year
follow-up of BCG vaccine Trial in this area showed
that there was no decline in the prevalence of
smear-positive cases over the period 1968-1986
(pre-SCC period) 6. Using available information
indicated in NTP, the efficiencies were about 30%
for case finding, 35% for  case holding, 80% for
chemotherapy and 50% for relative efficiency (ie.
the proportion of patients with successful
outcome even without completing their prescribed
course of treatment relative to the proportion with
a favourable response at the end of the prescribed
course). From these estimates, the success rate
was estimated to be only 16%7. The three
tuberculin surveys conducted among children aged
1- 9 years in 1969, 1979 and 1984 in this area
showed that there was no change in the prevalence
of infection namely, 9.0%, 10.2% and 9.1% and
the computed ARTI of 1.7%, 1.9% and 1.7%
respectively8.
A repeat survey conducted during 2001-
2003 after the baseline survey (1999-2001) in the
same population showed that the annual decline was
of 9% and 11% for smear-positive and culture-
positive cases respectively. The ARTI estimates from
the three tuberculin surveys conducted in the same
area among children aged <10 years during 1999-
2005 were 1.6%, 1.4% and 1.2% respectively9.
There was a significant decline in the trend of TB
infection (annual decline of 6%). An increase in the
success rate due to the implementation of the
effective DOTS strategy was in association with a
substantial reduction in the prevalence of TB and
infection as demonstrated from the disease and
tuberculin surveys carried out in the area.
The successful treatment outcome obtained
in our study was less than the national expected
average of 85%. The cure rate was 91% among the
category I patients treated under DOTS in one of
the chest diseases clinics run by the Municipal
Corporation of Delhi10.  The study concluded that
the cure rate could have been more if tracing of
defaulter had been intensified. Our study had a higher
default rate and we identified old age and alcoholism
as the independent risk factors necessitating targeted
health education programme through Information,
Education and Communication (IEC) for this group
of patients.  An earlier report from the same area
also recommended retrieval action of defaulters in
order to increase the successful treatment
outcome11.
We have correlated the activities of the
HFs in this area and the programme indicators
like conversion and cure12. Both were found to be
well correlated indicating that success of the
DOTS depends on the health function. This
emphasizes the need for periodic evaluation of the
functioning of each HF for better management of
treatment.
CONCLUSION
The study showed that an increase in the
successful treatment outcome of the patients treated
under DOTS was associated with substantial decline
in the prevalence of TB in the community. This would
be a milestone towards achieving the MDGs of
reverting and reducing the prevalence of TB by 50%
in 2015 related to 1990 levels.
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